NAMPT and polycystic ovary syndrome: Tian et al. (Tian et al., 2020) reported that visfatin protein expression was upregulated by the PI3K/AKT and MAPK/ERK signalling pathways in polycystic ovary syndrome (PCOS) patients with endometrial cancer.